A Study of GLB-001 in Patients With Myeloid Malignancies

Clinical trial NCT06378437 · RECRUITING

Trial details

NCT number: NCT06378437
Sponsor: Hangzhou GluBio Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Polycythemia Vera Essential Thrombocythemia Myelofibrosis Myelodysplastic Syndromes Acute Myeloid Leukemia Myeloid Malignancy

Start date: 2024-05-24
Primary completion: 2026-12-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.